Live Quote · NYSEEWHealthcare· Medical - Devices

Edwards Lifesciences Corporation

$94.37 2.59%(+$2.38)
TickerSpark Score
74/100
Solid
56
Valuation
85
Profitability
45
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EW research report →

52-Week Range100% of range
Low
$72.30
Current
$94.37
High
$94.47
Company Overviewwww.edwards.com

About the company

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems.

CEO
Bernard J. Zovighian
IPO
2000
Employees
15,800
HQ
Irvine, CA, US

Price Chart

+22.53% · this period
$94.37$83.51$72.65Jul 02Dec 31Jul 02
Valuation
Market Cap
$54.34B
P/E
49.93
P/S
8.62
P/B
5.29
EV/EBITDA
37.02
Div Yield
0.00%
Profitability
Gross Margin
78.01%
Op Margin
27.62%
Net Margin
17.34%
ROE
10.55%
ROIC
12.06%
Growth & Income
Revenue
$6.07B · 11.55%
Net Income
$1.07B · -74.28%
EPS
$1.84 · -73.64%
Op Income
$1.64B
FCF YoY
360.50%
Performance & Tape
52W High
$94.47
52W Low
$72.30
50D MA
$85.23
200D MA
$82.45
Beta
0.85
Avg Volume
5.18M

Get TickerSpark's AI analysis on EW

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 30, 26Lippis Daniel J.other619
Jun 30, 26Lippis Daniel J.sell619
Jun 30, 26Lippis Daniel J.other619
Jun 17, 26Zovighian Bernard Jsell523
May 29, 26Mistras Theodoraother0
May 29, 26Dahl Andrew M.sell567.527
May 27, 26BOBO DONALD E JRsell23,145
May 22, 26Chopra Daveensell1,500
May 18, 26Lippis Daniel J.other620
May 18, 26Lippis Daniel J.sell620
Coverage · EW

Our EW coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on EW yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate EW report →
Internal Compare

Similar companies

Peers in the same neighborhood.